Company intelligence / Profile preview

Zafrens

San Diego, California, United Stateszafrens.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Zafrens has developed a proprietary ultra-high-throughput drug discovery platform that enables the isolation, culture, imaging, and sequencing of millions of cells per day. This allows for comprehensive analysis of therapeutic assets across efficacy, safety, and mechanism dimensions. The company collaborates with leading pharmaceutical companies to accelerate breakthroughs in oncology, immunology, neuroscience, and other disease areas. No clinical results have been published as the focus is on preclinical research and technology partnerships.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Small moleculesBiologicsCell therapiesGene therapiesTCRs (T-cell receptors)RNA regulatory small moleculesCAR-T cellsBispecific antibodies
Industry: Biotech

Partnerships

Multiple leading pharmaceutical companies in undisclosed collaborations focused on various modalities including CAR-T optimization and bispecific antibody discovery.Academic or industry partners not specifically named.

Beyond the preview

Go deeper on Zafrens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zafrens.

Explore the full profile